These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15584904)
1. BCL-2-induced glioma cell invasiveness depends on furin-like proteases. Wick W; Wild-Bode C; Frank B; Weller M J Neurochem; 2004 Dec; 91(6):1275-83. PubMed ID: 15584904 [TBL] [Abstract][Full Text] [Related]
2. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365 [TBL] [Abstract][Full Text] [Related]
3. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202 [TBL] [Abstract][Full Text] [Related]
4. Pirfenidone inhibits TGF-beta expression in malignant glioma cells. Burghardt I; Tritschler F; Opitz CA; Frank B; Weller M; Wick W Biochem Biophys Res Commun; 2007 Mar; 354(2):542-7. PubMed ID: 17234158 [TBL] [Abstract][Full Text] [Related]
5. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491 [TBL] [Abstract][Full Text] [Related]
6. Involvement of furin-like proprotein convertases in the arterial response to injury. Sluijter JP; Verloop RE; Pulskens WP; Velema E; Grimbergen JM; Quax PH; Goumans MJ; Pasterkamp G; de Kleijn DP Cardiovasc Res; 2005 Oct; 68(1):136-43. PubMed ID: 15963479 [TBL] [Abstract][Full Text] [Related]
7. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287 [TBL] [Abstract][Full Text] [Related]
8. Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases. Leitlein J; Aulwurm S; Waltereit R; Naumann U; Wagenknecht B; Garten W; Weller M; Platten M J Immunol; 2001 Jun; 166(12):7238-43. PubMed ID: 11390472 [TBL] [Abstract][Full Text] [Related]
9. BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells. Weiler M; Bähr O; Hohlweg U; Naumann U; Rieger J; Huang H; Tabatabai G; Krell HW; Ohgaki H; Weller M; Wick W Cell Death Differ; 2006 Jul; 13(7):1156-69. PubMed ID: 16254573 [TBL] [Abstract][Full Text] [Related]
10. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway]. Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression. Platten M; Wick W; Wild-Bode C; Aulwurm S; Dichgans J; Weller M Biochem Biophys Res Commun; 2000 Feb; 268(2):607-11. PubMed ID: 10679251 [TBL] [Abstract][Full Text] [Related]
12. Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in Furin-Negative Colon Carcinoma LoVo Cells. Deryugina EI; Ratnikov BI; Yu Q; Baciu PC; Rozanov DV; Strongin AY Traffic; 2004 Aug; 5(8):627-41. PubMed ID: 15260832 [TBL] [Abstract][Full Text] [Related]
14. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Yoo YA; Kang MH; Kim JS; Oh SC Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246 [TBL] [Abstract][Full Text] [Related]
15. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Wild-Bode C; Weller M; Rimner A; Dichgans J; Wick W Cancer Res; 2001 Mar; 61(6):2744-50. PubMed ID: 11289157 [TBL] [Abstract][Full Text] [Related]
16. Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. López de Cicco R; Bassi DE; Zucker S; Seidah NG; Klein-Szanto AJ Cancer Res; 2005 May; 65(10):4162-71. PubMed ID: 15899807 [TBL] [Abstract][Full Text] [Related]
18. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. Wick W; Platten M; Weller M J Neurooncol; 2001 Jun; 53(2):177-85. PubMed ID: 11716069 [TBL] [Abstract][Full Text] [Related]
19. The structure of the TGF-beta latency associated peptide region determines the ability of the proprotein convertase furin to cleave TGF-betas. Kusakabe M; Cheong PL; Nikfar R; McLennan IS; Koishi K J Cell Biochem; 2008 Jan; 103(1):311-20. PubMed ID: 17516499 [TBL] [Abstract][Full Text] [Related]
20. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]